PLAY PODCASTS
Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh
Episode 489

Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh

Talking Biotech with Dr. Kevin Folta · Colabra

February 27, 202646m 30s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.

Topics

Keywords Bonum Therapeuticsconditionally active biologicsimmunotherapycancer treatmentmonoclonal antibodiesdrug developmentcytokinestargeted therapyimmuno-oncologybiotechnology